restricted peptide antigen derived from gp70 amino acids 423-431, referred to as AH1 (SPSYVYHQF), which is the dominant target for the CD8 T cell responses against the CT26 colorectal tumor (Huang et al., 1996) . gp70 expression is silent in most normal tissues but is active in many mouse tumors (Huang et al., 1996) . According to a computer algorithm developed to rank order the half-time of disassociation of peptide to MHC, AH1 is predicted to bind H-2L (Huang et al., 1996) . As with
MHC-Peptide-TCR Complex
To determine the influence of TCR affinity for MHCmost natural tumor antigens derived from self-proteins, AH1 peptide is a relatively weak immunogen when used peptide complex on immunogenicity, we studied TCR binding to the natural H-2L d -AH1 complex as well as to independently from the tumor as a vaccine against CT26 even though it is a good target for activated antigena panel of alanine-substituted variant peptides. To overcome the intrinsically low affinity of MHC-peptide for specific CTL (Huang et al., 1996 (Robinson and Lee, 1996) . Peptides with substituted residues 4, 6, 7, 8, and 9 resulted in background-level at the lower peptide concentrations (Figure 1 ). pMCMV has previously been shown to be a high-affinity H-2L d to the TCR was not detected as expected demonstrating specificity. Independently, the kinetic dissociation rate constants (k off ) for each interaction were determined using a direct fit algorithm (Table 1 ) with the assumption of 1:1 Langmuir binding. Based on the measured K D and k off , the kinetic association rate constants, k on , were calculated. As shown in Table 1 , the on rates of the AH1 and AH1-A5 peptide complexes were similar. However, the off rate of the AH1-A5 complex was about 3-fold slower than the AH1 complex accounting for the difference in affinity. The on rate of the H-2L , and CD8-cychrome (PharMingen) were also included with the avidin-PE to facilitate al., 1996). The T cell clones were stimulated in vitro every 7 days as described (Huang et al., 1996) . Splenocytes were stimulated in detection of the CD8 ϩ cells. For visualization of peptide-loaded H-2L d complexes, T2-Ld cells vitro by the same method. In brief, the spleens were crushed and red blood cells were lysed (Kruisbeek, 1993) . After two washes in were incubated overnight at 25ЊC. T2-Ld cells were then incubated with 10 M peptide for 2 hr at 37ЊC. Approximately 1 g CT-Ig was complete medium, the 4 ϫ 10 6 cells were combined with 1 ϫ 10 5 mitomycin C-treated CT26-B7 and 10 units/ml IL-2 in 2 ml complete added to either 3 ϫ 10 5 T2-Ld cells or peptide-pulsed dendritic cells, the cells were incubated on ice for 1-2 hr, and, then visualized by medium in 24-well plates.
Dendritic cells were generated from the spleen as described (Inaba flow cytometry as described with Ld-Ig. The antibody 14-4-4, which recognizes MHC class II (American Type Cell Collection), anti-CD80, et al., 1998). The dendritic cells were loaded overnight in 100 or 300 g/ml peptide in serum-free AIMV medium supplemented with 0.1 mM which recognizes B7.1 (PharMingen), and CD11c (PharMingen) were used in analyzing the cell surface marker of the dendritic cells. ␤-mercaptoethanol, 100 units/ml penicillin, and 100 units/ml streptomycin. Excess peptide was removed in three washes of Hanks buffer (Gibco).
Chromium Release Assays
One million target cells were labeled in 100 l complete medium and 200 Ci
51
Cr at 37ЊC for 1-1.5 hr. Target cells were washed three Construction, Expression, and Purification of Ld-Ig and CT-Ig Ld-Ig, the divalent H-2L d protein was constructed, expressed, and times to remove excess chromium. To determine which peptides mediate lysis of the AH1-specific clone, 51 Cr-labeled MC57G-Ld purified using described methods (Schneck et al., 1999) 
